FindTrial
Sign In

Sex life of cervical cancer patients undergoing chemoradiotherapy

Sexual quality of life in cervical cancer patients undergoing chemoradiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/03/041125
Enrollment
100
Registered
2022-03-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 2: C539- Malignant neoplasm of cervix uteri, unspecified Health Condition 3: C539- Malignant neoplasm of cervix uteri, unspecified

Interventions

Intervention1: Radiotherapy: Patient will undergo chemoradiotherapy along with 5 cycles of concurrent chemotherapy cisplatin (40 mg/m2 ) Dose : 46 Gy in 23 fractions Duration : 4 1/2 weeks Interv

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Previously untreated biopsy proven squamous cell carcinoma of cervix 2. Age 18 - 70 years 3. ECOG - 1 4. Sexually active patients prior to diagnosis

Exclusion criteria

Exclusion criteria: 1. Patients who have undergone surgery for cervical cancer 2. Cancer cervix as second primary 3. Patients with severe co morbidities.

Design outcomes

Primary

MeasureTime frame
To compare sexual quality of life in cervical cancer patients at baseline, 3 months and 6 months post treatmentTimepoint: Baseline 3 months 6 months—

Secondary

MeasureTime frame
1. To compare the sexual quality of life with age matched controls 2. To analyze the dosimetric and clinical factors influencing sexual quality of life.Timepoint: Baseline—

Countries

India

Contacts

Public ContactBHAVANA RAI

PGIMER

bhavana1035@gmail.com9814635706

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026